Dalbavancin for the treatment of acute bacterial skin and skin structure infections.
Le infezioni in medicina, 2017 Dalbavancin is a novel parenteral lipoglycopeptide antibiotic approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in adults. Dalbavancin is highly active against common Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA).
Silvano, Esposito +2 more
openaire +1 more source
Invited review: Camel skin diseases survey in Morocco [PDF]
, 2019 The present study aimed to collect data related to skin diseases in dromedary camels in the south of Morocco. As a whole, 168 herds from 9 provinces located in the south of Morocco have been prospected.
Bengoumi, Mohammed +3 more
core
Infection and Drug Resistance, 2015 Ronald G Hall 2nd, Heidi N Michaels Texas Tech University Health Sciences Center, Dallas, TX, USA Abstract: Tedizolid phosphate is the first once-daily oxazolidinone approved by the United States Food and Drug Administration for the treatment of acute ...
Hall RG 2nd, Michaels HN
doaj
Clinical application of penicillin [PDF]
, 1949 Mostly reprintsIncludes bibliographical references.10 pts. in 1 v.Title page and introduction only. The complete thesis in print form is available from the University Library.Thesis (M.D.)--University of Adelaide, Dept.
Florey, Mary Ethel Hayter (Reed), Lady
core
Infection and Drug Resistance, 2016 Travis M Jones,1,2 Steven W Johnson,1,3 V Paul DiMondi,1,4 Dustin T Wilson,1,2 1Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, 2Department of Pharmacy, Duke University Hospital, Durham ...
Jones TM +3 more
doaj
Interdisciplinary MedicineThe emergence of antibiotic‐resistant bacteria poses a significant challenge to the prompt and appropriate treatment of pathogenic bacteria infections, such as acute bacterial skin and skin‐structure infections (ABSSSI), especially in the presence of ...
Ji Wang +8 more
doaj +1 more source
The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections. [PDF]
Pediatr Infect Dis J, 2023 Giorgobiani M +7 more
europepmc +1 more source
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals. [PDF]
JAC Antimicrob Resist, 2023 Bai F +7 more
europepmc +1 more source
Real-world effectiveness of omadacycline and impact of unapproved omadacycline prescription claims among adult outpatients with community-acquired bacterial pneumonia or acute bacterial skin and skin structure infections. [PDF]
J Manag Care Spec Pharm, 2023 Lodise TP +7 more
europepmc +1 more source
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections
Drug Design, Development and Therapy, 2013 Olatz Urbina,1 Olivia Ferrández,1 Mercè Espona,1 Esther Salas,1 Irene Ferrández,2 Santiago Grau1 1Services of Hospital Pharmacy, Hospital Universitari del Mar, Universitat Autònoma de Barcelona, 2Ciència i Tecnologia ...
Urbina O +5 more
doaj